Whipple procedure: A review of a 7-year clinical experience in a referral center for hepatobiliary and pancreas diseases by Saraee, A. et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Saraee et al. World Journal of Surgical Oncology  (2015) 13:98 
DOI 10.1186/s12957-015-0523-8RESEARCH Open AccessWhipple procedure: a review of a 7-year clinical
experience in a referral center for hepatobiliary
and pancreas diseases
Amir Saraee1, Jalal Vahedian-Ardakani2, Ehsan Saraee3, Roshanak Pakzad4 and Massoud Baghai Wadji2*Abstract
Background: Pancreatic cancer is generally found in the older population Pancreaticoduodenectomy seems to be the
only way in resolving these resectable tumors. Allen. O Whipple was the first to describe pancreaticoduodenectomy in
1935 as a modified procedure. This article is a case series with respect to the 7-year experience of the Whipple
procedure in Firoozgar Teaching Hospital.
Methods: Patient surgery details were gathered from the surgical records of the operating room and their clinical
records from the hospital archives. Data was analyzed with SPSS software (version 16.0.1). Those patients, whose tumor
had invaded the superior mesenteric artery, had extensive portal vein involvement or distant metastasis was
considered as unresectable.
Results: The first Whipple procedure was recorded in our hospital in 2008. From 2008 till 20 March 2014, 70 cases were
collected and analyzed. The mean age of cases was 58.4 years, the mean hospital stay length was 12.9 days
(±6.23 days), mean operation time was 376 min (±37.3 min),. The most common presenting symptom was jaundice
(78.6 %). Delayed gastric emptying was the most common post-operative complication. The most prevalent cause of
reoperation was intra-abdominal abscess. Major morbidities of these patients consisted of cardiac arrhythmias (21.4%)
and pneumonia (10%). Minor complications were wound infection (17.1%) and delayed gastric emptying (32.9%). The
statistics revealed pancreatic anastomosis failure as 2.9% and a decrease in mortality rate from 50% during the first years
of this study to 16% to 20% during the last years.
Conclusions: In this case series, the time of operation decreased during the recent years .Analysis shows a correlation
between operation time and pack cell transfused during the operation, but no correlation was found between
operation time and post-operation hospitalization course. It is true that hospital setting, socioeconomic level of the
patients including their compliance, and the expertise of the surgeons and surgical staff can have an influence on the
result of this operation, but it seems that the magnitude of the surgical stress of this procedure and the (compromised)
functional reserve of this patient population can be a notable factor influencing the outcome.
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Pancreatic cancer is one of the most important causes of
death in eastern countries and the fourth cause of death
from cancer in the western hemisphere. Only a few per-
cent of patients can survive from this condition for more
than 5 years. Most patients present with an advance* Correspondence: baghaiw@yahoo.com
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unless otherwise stated.stage of the disease, and only in 10% to 20% of them the
mass is resectable. There are some factors for predicting
the prognosis, such as size of the tumor, degree of differ-
entiation, status of resected lymph nodes, and the in-
volvement of the resected margins. In some articles, the
post-resection CA 19-9 level and tumor DNA content
were also mentioned as prognostic factors. Among vari-
ous treatments for pancreatic cancers, surgery was the
only chance for cure [1].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Stage of tumor before operation






No staging was present 48
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known, but tobacco is the most probable reason. Risk in-
creases with longer exposure to smoke and greater
tobacco usage. There is some evidence that alcohol, cof-
fee, and aspirin consumption are among the predispos-
ing factors. Other risk factors are history of diabetes or
chronic pancreatitis, chronic cirrhosis, and patients with
blood type A, B, or AB. Only 5% to 10% of these patients
have a positive familial history of pancreatic cancer [2].
For the first time, Allen. O Whipple described pan-
creaticoduodenectomy in the year 1935 when he modi-
fied the procedure that was performed before by
Alessendro Codinivillan in Italy and Walter Keusch in
Germany [3].
In a similar study at the Massachusetts hospital [4],
pancreatic cancer cases that required surgery were
followed and improvements in Whipple procedure were
reported. The aim of this study is to evaluate the evolu-
tion of this procedure from 2008 to 2014 in our hospital
and analyze the statistics pertaining to the presenting
signs and symptoms, Whipple procedure, and the clin-
ical post-operation courses.
Methods
Data regarding the surgery was extracted from the ar-
chives of Firoozgar General Hospital, and further infor-
mation was obtained from the medical records from
2008 to 2014. Data related to the ‘pancreaticoduodenect-
omy’ or ‘whipple’ procedures were gathered using a
checklist designed for this study. The data was analyzed
using the SPSS software (version 16.0.1). The parameters
and variables of the study were patient demographic
data, presenting symptoms, physical signs, past medical
history, intra-operative parameters, post-operative com-
plications, pathology, causes of post-operative death,
cause of readmission, and cause of reoperation. Those
patients, whose tumor had invaded the superior mesen-
teric artery, had extensive portal vein involvement, or
distant metastasis was considered as unresectable. None
of the patients received neoadjuvant chemotherapy.
Results
A number of 70 procedures were performed till 2014 by
three different surgeons. As a mean, our center performs
10 procedures per year but the number of procedures
had increased from 2 operations in 2008 to 25 opera-
tions in 2014.
Analyses have shown the mean age of cases as
58.4 years with 40% of the gender being male. A portion
of patients (35.1%) were greater than 65 years of age.
The minimum age was 29; the oldest patient being
78 years old.
Prevalence of diabetes mellitus before surgery was
13.5%; among them, 5% were on medication with oralagents and 2.7% with insulin. Meanwhile, 91.9% of the
diabetic patients were not receiving any medication.
After the procedure, 27% of patients had new onset dia-
betes mellitus. In this case series, the percentage of alco-
hol consumers was 2.7%, and 21.6% of patients were
smokers. One patient (2.7%) was addicted to opium.
About 13.5% of them had a positive family history of
cancer, and of them, 32.5% had pancreatic cancer.
The most common presenting symptom was jaundice
(78.6%). Among them, 70% complained of abdominal
pain. Other symptoms in order of frequency are weight
loss, anorexia, nausea, vomiting, and fever.
Pathology
Eight and a half percent (8.5%) of cases had benign le-
sions, but the main indication for pancreaticoduodenect-
omy was malignancy in the pancreas. In this study, the
most common pathology was adenocarcinoma; 62.2% of
them were well differentiated.
The lymph nodes were involved by the tumor in 35.1%
of cases. The surgical pathology studies were as follows:
two patients had intestine type adenocarcinoma, four
had neuroendocrine tumors, and in one case, granulocy-
tosis paraganglioma was observed. A 29-year-old woman
had duodenal large-cell malignant lymphoma (diffuse
type). Her presenting symptoms were weight loss, an-
orexia, and vomiting.
There were benign lesions in 5.9% of cases, like aden-
omatous dysplasia of the duodenum. About 52.9% of ma-
lignancies were periampulary lesions, and 38.6% of them
were neoplasms of the pancreas. Liver metastasis and ab-
dominal wall seeding was considered as unresectable.
Among patients who underwent staging before surgery,
stage IIB was the most common stage. Unfortunately,
there was no sufficient data in the archives regarding the
staging of the other 48 patients (Table 1).
Operation course
The mean operation time was 376 min (±37.3 min), and
intra-operative blood transfusion was approximately 1.84
pack cells each operation (Table 2).
The mean age of patients was 58.4 years; the mean ad-
mission length was 12.9 days (±6.23 days). Of them,
Table 2 Changes of operation time, used pack cell during
operation, and post-hospitalization days during the
time spent








mean (day) ± SD
2008 4.9 ± 0.06 3 17 ± 0.7
2009 5.7 ± 1.12 6 17 ± 5.7
2010 5.0 ± 0.51 4 8 ± 6.4
2011 4.2 ± 0.53 2 10 ± 5.7
2012 5.0 ± 0.78 3 17 ± 13
2013 4.5 ± 0.33 2 15 ± 6.9
2014 5.2 ± 1.02 1 11 ± 5.2
Table 3 Complications
Complications Number Percent
Delayed emptying 23 32.9%
Cardiac complications 15 21.4%
Wound infection 12 17.1%
Pneumonia 7 10.0%
Hemorrhage 5 7.1%
GI leakage 5 7.1%
Renal failure 4 5.7%
Biliary fistula 2 2.9%
Pancreatic fistula 0 0.0%
Cholangitis 0 0.0%
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loss was seen in 16.2% of them, and 8.1% of them cases
had foul stool after surgery.
The common technique for reconstruction in our
study was classic pancreaticojejunostomy (83.8%). In one
case, we repaired the transverse mesocolon that was in-
jured inadvertently.
In some cases, the major vessels were involved by the
tumor. If the SMA was involved, the case was consid-
ered inoperable and excluded from this study. SMV or
portal vein could be repaired if less than 180° of the cir-
cumference of portal vein was involved by the tumor. In
this case series, vascular reconstruction was performed
in 13 patients (11.4% portal reconstruction, 7.1% SMV
reconstruction). Vascular repair was performed due to
vein involvement by tumor or iatrogenic injury.Complications
The most common complication after surgery was delayed
gastric emptying (32.9%). GI leakage was related to failure
of gastro-jejunostomy anastomosis, and biliary fistula was
secondary to choledocojejunostomy anastomosis disrup-
tion or leakage. Major morbidities of these patients con-
sisted of cardiac complications like cardiac arrhythmias
(21.4%), pneumonia (10%), hemorrhage (7.1%), biliary
fistula (2.9 %), and renal failure (5.7%). Minor complica-
tions were wound infection (17.1%) and delayed empty-
ing (32.9 %) (Table 3).Table 4 Post-operative death
Early post-op death Number Percent
Septic shock 7 10
Massive GI bleeding 3 4.3
PTE 1 1.4
Hypovolemic shock 1 1.4
ARDS 1 1.4
Acute MI 0 0.0Reoperation
The most common cause for reoperation was intra-
abdominal abscess (21.4%). Other causes of reoperation
were bleeding in one case and obstruction in two. Biliary
cutaneous fistula was seen in two patients, and one was
operated twice due to bowel obstruction. Other causes
of reoperation consist of wound dehiscence, tracheos-
tomy, and gastrojejunostomy revision.Readmission
Thirty-seven (37%) percent of cases were readmitted due
to various problems. After nausea and vomiting as the
most common reason of readmission in 24.2% of cases,
the second reason was pneumonia (19.24%). In order of
decreasing frequency, other readmission causes were
wound infection, controlling blood sugar, intra-abdominal
abscess, GI bleeding, and fever.
Post-operation course
In the early post-operative mortality group (death below
1 month after operation), seven cases died due to septic
shock, three of them had massive gastrointestinal bleed-
ing, and one patient had pulmonary thromboembolism
(Table 4). The patients with septic shock were consid-
ered as a probable failure of pancreatic anastomosis
since there was no site of infection in other organs, and
autopsy was not allowed to be performed by one pa-
tient’s family.
Discussion
Pancreatic cancer is the fourth leading cause of cancer
death because of short-term survival time, regardless of
its stage. The main etiology of pancreatic cancer is un-
known, though the incidence of pancreatic cancer is 2.5
to 3.6 times more in smokers. There also exists some
evidence that alcohol, coffee, and aspirin consumption
can lead to pancreatic cancer. The presenting symptoms
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stage of the tumor [2]. Pancreatic cancer is mostly seen
in the elderly, and the overall 5-year survival rate is
below 5% [5-7].
The histologic precursor best characterizing pancreatic
cancer is intra-epithelial neoplasia [8]. Dens stroma
termed as desmoplastic reaction in pathological assess-
ment is also characteristic of pancreatic cancer [9].
Allen Oldfather Whipple modified the pancreatico-
duodenectomy procedure in 1935 [3,10,11]. Surgical bil-
iary and gastric bypass was superior to endoscopic
intervention in terms of quality of life improvement and
decreasing rate of re-hospitalization and re-intervention
[12]. Nowadays, Whipple is an acceptable operation that
is performed in various malignant and benign diseases of
pancreas and periampulary area [13].
During the past 7 years of our experience in this pro-
cedure, an improvement in the different aspects of the
technique including lesser time of operation, less intra-
operative bleeding, less pancreatic anastomosis failure,
and decrease in hospital staying days. Pancreatic anasto-
mosis was performed in two layers with non-absorbable
suture material and in an end-to-end and invagination
technique. In some cases, omentum was used as a bar-
rier between the site of pancreatic anastomosis and su-
perior mesenteric vein.
Though the statistics reveal a pancreas anastomosis fail-
ure of 2.9% but due to the lack of autopsy findings, the au-
thors consider it as 10% because of sepsis with unknown
origin. There was decreasing in mortality rate from 50%
during the first year of this study (among two patients) to
16% to 20% during the last years (among 25 patients).
The number of this procedure has increased in our
center during the recent years due to developing an ad-
vanced gastrointestinal department and a referring sys-
tem from that ward. Although complications of this
surgery are still observed in our hospital, its decreased
rate could be attributed to better surgical techniques,
better post-operation intensive care, and improved surgi-
cal staff expertise and more accurate patient selection.
Post-operation hospitalization duration has decreased
too except for in some complicated cases.
We found a meaningful correlation between operation
time and packed blood cell transfused intra-operatively
(P value <0.05) but no correlation has been found be-
tween operation time and the length of hospitalization.
According to the surgical pathologic study, four pa-
tients had well-differentiated neuroendocrine tumor
(NET). The mean age of this group was 61.75 years, and
the average hospitalization time was 13.5 days. Three of
the four patients were female. It is notable that although
the tumor had invaded the superior mesenteric vein or
portal vein in two patients, none of them had jaundice.
It could be assumed that NET could have enlarged bulkof mass without resulting in obstructive jaundice, but
adenocarcinoma causes jaundice even with a smaller
tumor size. The most common presenting sign of NET
was vomiting and abdominal pain. In spite of their bur-
den, these tumors could be resected easier than adeno-
carcinoma. Survival of this group was greater than other
pathologies (average = 36 months). Two cases in this
group survived for 72 and 60 months after surgery.
None of them have expired till date.
Several studies have reported the effect of treating a
high volume of patients on post-operative outcomes.
The definition of high and low volume varied among all
these studies from 15 patients to 40 patients per year.
Birkmeyer et al. have reported a marked difference in
mortality rates of Whipple procedure in very low-volume
(zero or one patient per year) and low-volume (one or two
per year) hospitals compared with higher-volume hospitals
(less than five per year). Surgeons who performed fewer
than four resections per year had more complications than
those who performed more than four [14].
On the other hand, mortality rates at very low and
low-volume hospitals were significantly higher than
those at high-volume hospitals.
Conclusions
Though pancreaticoduodenectomy is the treatment of
choice in the patients with periampulary carcinoma and
in spite of its introduction to the medicine 80 years ago,
it still has significant mortality and morbidity even in
high volume centers.
It is true that hospital setting, socioeconomic level of
the patients including their compliance, and the expert-
ise of the surgeons and surgical staff can have influence
over the result of this operation; it seems that the mag-
nitude of the surgical stress of this technique and the
compromised functional reserve of these patient popula-
tion can be a notable factor influencing the outcome.
Even though our data strongly suggests - as other
studies - that pancreatic resections should be carried out
at institutions that perform a large number of them an-
nually, it should be kept in mind whether the extent of
operation can be reduced in the future.
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